Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study

Prediction of coronary heart disease using risk factor categories

Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581

Cardiovascular Survey Methods.

Rose, G., & Blackburn, H. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,090

Validation of the Framingham Coronary Heart Disease Prediction Scores: Results of a Multiple Ethnic Groups Investigation

D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108

An updated coronary risk profile. A statement for health professionals.

Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834

AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES

Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study

Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541

Prevention of coronary heart disease in clinical practice

Pyörälà, K., Backer, G. D., Graham, I. M., Poole-Wilson, P. A., & Wood, D. A. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060388 · Cited by 1,161

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations

Kuulasmaa, K., Tunstall‐Pedoe, H., Dobson, A. J., Fortmann, S. P., Sans, S., Tolonen, H. K., Evans, A., & Ferrario, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11180-2 · Cited by 950

The Framingham Offspring Study

Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_25 · Cited by 832

Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts

Hense, H. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00081-2 · Cited by 370

Attainment of low-density lipoprotein cholesterol target in the French general population according to levels of cardiovascular risk: Insights from the MONA LISA study

Bongard, V., Dallongeville, J., Arveiler, D., Ruidavets, J., Amouyel, P., Wagner, A., & Ferrières, J. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2012.11.003 · Cited by 27

Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies

Empana, J. P., Tafflet, M., Escolano, S., Vergnaux, A., Bineau, S., Ruidavets, J., Montaye, M., Haas, B., Czernichow, S., Balkau, B., et al. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826710389354 · Cited by 28

Comparison of the Framingham risk and score models in predicting the presence and severity of coronary artery disease considering SYNTAX score

Günaydın, Z. Y., Karagöz, A., Bektaş, O., Kaya, A., Kırış, T., Erdoğan, G., Işık, T., & Ayhan, E. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2015.6317 · Cited by 27

A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men

May, M., Sterne, J. A. C., Shipley, M. J., Brunner, E. J., D’Agostino, R. B., Whincup, P. H., Ben‐Shlomo, Y., Carr, A. D., Ledergerber, B., Lundgren, J. D., et al. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym135 · Cited by 27

Perspectives on mortality forecasting

Bengtsson, T., & Keilman, N. (2003) · Cited by 26

External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study

Majed, B., Tafflet, M., Kee, F., Haas, B., Ferrières, J., Montaye, M., Ruidavets, J., Arveiler, D., Yarnell, J., Amouyel, P., et al. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.04.003 · Cited by 25

Development of a diagnosis model for coronary artery disease

Xu, H., Duan, Z., Miao, C., Song, G., & Jin, Y. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.02.022 · Cited by 26

Estimating the burden of cardiovascular risk in community dwellers over 40 years old in South Africa, Kenya, Burkina Faso and Ghana

Wagner, R. G., Crowther, N. J., Micklesfield, L. K., Boua, P. R., Nonterah, E. A., Mashinya, F., Mohamed, S. F., Asiki, G., Tollman, S. M., Ramsay, M., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-003499 · Cited by 24

SCORE should be preferred to Framingham to predict cardiovascular death in French population

Marchant, I., Boissel, J., Kassaï, B., Bejan‐Angoulvant, T., Massol, J., Vidal, C., Amsallem, E., Naudin, F., Galan, P., Czernichow, S., et al. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832da006 · Cited by 24

Capacidad predictiva de las funciones de riesgo cardiovascular: limitaciones y oportunidades

Baena-Díez, J. M., Ramos, R., & Marrugat, J. (2009) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(09)71500-6 · Cited by 24

Antiatherosclerotic and Cardioprotective Effects of Time-Released Garlic Powder Pills

Карагодин, В. П., Sobenin, I. A., & Orekhov, A. N. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612822666151112153351 · Cited by 24

Concordance evaluation of coronary risk scores: implications for cardiovascular risk screening

Reynolds, T., Twomey, P. J., & Wierzbicki, A. S. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003647 · Cited by 23

Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe

Hermansson, J., & Kahan, T. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0578-1 · Cited by 23

Ten-year risk of all-cause mortality: assessment of a risk prediction algorithm in a French general population

Bérard, E., Bongard, V., Arveiler, D., Amouyel, P., Wagner, A., Dallongeville, J., Haas, B., Cottel, D., Ruidavets, J., & Ferrières, J. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9541-6 · Cited by 23

Cardioinformatics: the nexus of bioinformatics and precision cardiology

Khomtchouk, B. B., Tran, D.-T. T., Vand, K. A., Might, M., Gozani, O., & Assimes, T. L. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz119 · Cited by 23

Development of a nomogram that predicts the risk for coronary atherosclerotic heart disease

Huang, S., Xie, X., Sun, Y., Zhang, T., Cai, Y., Xu, X., Li, H., & Wu, S. (2020) · Aging · doi:10.18632/aging.103216 · Cited by 23

Monocyte subtype counts are associated with 10-year cardiovascular disease risk as determined by the Framingham Risk Score among subjects of the LIFE-Adult study

Zeynalova, S., Bucksch, K., Scholz, M. R., Yahiaoui‐Doktor, M., Groß, M., Löffler, M., Melzer, S., & Tárnok, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247480 · Cited by 23

Effect of an Educational Program (PEGASE) on Cardiovascular Risk in Hypercholesterolaemic Patients

Bruckert, É., Giral, P., Paillard, F., Ferrières, J., Schlienger, J.-L., Renucci, J.-F., ABDENNBI, K., Durack-Bown, I., Chadarévian, R., & PEGASE group (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6137-4 · Cited by 22

Dyslipidaemia and global cardiovascular risk: clinical issues

Assmann, G. (2006) · European Heart Journal Supplements · doi:10.1093/eurheartj/sul040 · Cited by 23

Two Unconventional Risk Factors for Major Adverse Cardiovascular Events in Subjects with Sexual Dysfunction: Low Education and Reported Partner’s Hypoactive Sexual Desire in Comparison with Conventional Risk Factors

Rastrelli, G., Corona, G., Fisher, A. D., Silverii, G. A., Mannucci, E., & Maggi, M. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02947.x · Cited by 21

Risk Functions and the Primary Prevention of Cardiovascular Disease

Grau, M., & Marrugat, J. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60141-3 · Cited by 21

Early detection of coronary artery disease by 64-slice multidetector computed tomography in asymptomatic hypertensive high-risk patients

Gaudio, C., Mirabelli, F., Pelliccia, F., Francone, M., Tanzilli, G., Michele, S. D., Leonetti, S., Vincentis, G. D., Carbone, I., Mangieri, E., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.091 · Cited by 20

Between risk charts and imaging: how should we stratify cardiovascular risk in clinical practice?

Mureddu, G. F., Brandimarte, F., Faggiano, P. M., Rigo, F., & Nixdorff, U. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes297 · Cited by 20

Primary prevention of coronary artery disease among middle aged men in Prague: Twenty-year follow-up results

Boudík, F., Reissigová, J., Hrach, K., Tomečková, M., Bultas, J., Anger, Z., Aschermann, M., & Zvárová, J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.011 · Cited by 19

Ultrasensitive Troponin I and Incident Cardiovascular Disease

Empana, J. P., Lerner, I., Perier, M., Guibout, C., Jabre, P., Bailly, K., Andrieu, M., Climie, R. E., van Sloten, T. T., Vedie, B., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.317961 · Cited by 18

The relative value of metabolic syndrome and cardiovascular risk score estimates in premature acute coronary syndromes

Kalantzi, K. J., Korantzopoulos, P. G., Tzimas, P. G., Katsouras, C. S., Goudevenos, J. A., & Milionis, H. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.10.038 · Cited by 18

Methodological issues in cardiovascular epidemiology: the risk of determining absolute risk through statistical models

Panagiotakos, D. B., & Stavrinos, V. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.309 · Cited by 18

Kardiovaskul�re Risikosch�tzung f�r eine informierte Patientenentscheidung

Lenz, M., & M�hlhauser, I. (2004) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-004-1097-3 · Cited by 18

Ten-year risk prediction in French men using the Framingham coronary score: Results from the national SU.VI.MAX cohort

Vergnaud, A., Bertrais, S., Galan, P., Herçberg, S., & Czernichow, S. (2008) · Preventive Medicine · doi:10.1016/j.ypmed.2008.02.023 · Cited by 18

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration

Vandenbroucke, J. P., von Elm, E. B., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S., Poole, C., Schlesselman, J. J., & Egger, M. (2022) · Вопросы современной педиатрии · doi:10.15690/vsp.v21i3.2426 · Cited by 19

Risk for cardiovascular events in an Italian population of patients with type 2 diabetes

Pellegrini, E., Maurantonio, M., Giannico, I. M., Simonini, M., Ganazzi, D., Carulli, L., D’Amico, R., Baldini, A., Loria, P., Bertolotti, M., et al. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.02.022 · Cited by 17

The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona

Herrera, S., Guelar, A., Sorlí, L., Vila, J., Molas, E., Grau, M., Marrugat, J., Esteve, E., Güerri‐Fernández, R., Montero, M., et al. (2016) · HIV Clinical Trials · doi:10.1080/15284336.2016.1177266 · Cited by 17

VTE Risk assessment – a prognostic Model: BATER Cohort Study of young women

Heinemann, L. A. J., DoMinh, T., Assmann, A., Schramm, W., Schürmann, R., Hilpert, J., & Spannagl, M. (2005) · Thrombosis Journal · doi:10.1186/1477-9560-3-5 · Cited by 17

Applicability of Framingham risk equations for studying a low-income mexican population

Jiménez-Corona, A., López‐Ridaura, R., Williams, K., González-Villalpando, M. E., Simón, J., & González‐Villalpando, C. (2009) · Salud Pública de México · doi:10.1590/s0036-36342009000400006 · Cited by 16

HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy

Sterne, J. A. C., May, M., Bucher, H. C., Ledergerber, B., Furrer, H., Cavassini, M. L., Bernasconi, E., Hirschel, B. J., Egger, M., & Study, T. S. H. C. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01761.x · Cited by 16

What is the Ideal Blood Pressure Goal for Patients with Stage III or Higher Chronic Kidney Disease?

Khouri, Y. S., Steigerwalt, S. P., Alsamara, M., & McCullough, P. A. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0215-0 · Cited by 15

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. Translation to Russian

Vandenbroucke, J. P., von Elm, E. B., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S., Poole, C., Schlesselman, J. J., & Egger, M. (2021) · Digital Diagnostics · doi:10.17816/dd70821 · Cited by 18

Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease

Vrentzos, G. E., Papadakis, J. A., Ganotakis, E. S., Paraskevas, K. I., Gazi, I. F., Tzanakis, Ν., Nair, D. R., & Mikhailidis, D. P. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01527.x · Cited by 15

Is exercise testing useful to improve the prediction of coronary events in asymptomatic subjects?

Cournot, M., Taraszkiewicz, D., Galinier, M., Chamontin, B., Boccalon, H., Hanaire, H. P., Puel, J., & Ferrières, J. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000198447.26613.3d · Cited by 14

Cardiovascular Risk Estimation and Eligibility for Statins in Primary Prevention Comparing Different Strategies

Nanchen, D., Chioléro, A., Cornuz, J., Marques-Vidal, P. M., Firmann, M., Mooser, V., Paccaud, F. M., Waeber, G., Vollenweider, P., & Rodondi, N. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.12.042 · Cited by 13

Assessment of Cardiovascular Risk

Cooney, M. T., Cooney, H. C., Dudina, A. L., & Graham, I. M. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0143-1 · Cited by 15

Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland

JAUSSI, A., Noll, G., Meier, B., & Darioli, R. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328333c1d9 · Cited by 14

A novel, privacy-preserving cryptographic approach for sharing sequencing data

Cassa, C. A., Miller, R. A., & Mandl, K. D. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-001366 · Cited by 14

Assessment of cardiovascular risk in primary care patients in France

Bruckert, É., Bonnelye, G., Thomas‐Delecourt, F., André, L., & Delaage, P.-H. (2011) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2011.04.007 · Cited by 13

A multiple biomarker risk score for guiding clinical decisions using a decision curve approach

Hughes, M., Saarela, O., Blankenberg, S., Zeller, T., Havulinna, A. S., Kuulasmaa, K., Yarnell, J., Schnabel, R. B., Tiret, L., Salomaa, V. V., et al. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711417341 · Cited by 13

Cardiovascular high-risk patients--treat to protect, but whom?

Zannad, F. M., Jakobsen, A., Heroys, J., Ralph, A., Rees, T., & Shaw, M. (2008) · PubMed · Cited by 13

Framingham-Grundy, REGICOR y SCORE en la estimación del riesgo cardiovascular del paciente hipertenso. Concordancias y discrepancias (CICLO-RISK)

García‐Ortiz, L., Gómez-Marcos, M. Á., González-Elena, L. J., Rodríguez‐Sánchez, E., García, Á. G., Parra-Sánchez, J., García, A. M. G., Rodríguez, C. H., & Barrientos, L. M. (2006) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(06)71615-4 · Cited by 13

Current possibilities for detecting high risk of cardiovascular disease

Simon, A. C., Mijiti, W., Gariépy, J., & Levenson, J. A. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.11.013 · Cited by 13

Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians

Haren, M. T., Li, M., Petkov, J., & McDermott, R. A. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-454 · Cited by 12

Impact of preclinical carotid atherosclerosis on global cardiovascular risk stratification and events in a 10-year follow-up: comparison between the algorithms of the Framingham Heart Study, the European SCORE and the Italian ‘Progetto Cuore’

Novo, S., Carità, P., Voi, A. L., Muratori, I. M., Tantillo, R., Corrado, E., Kalodiki, E., & Novo, G. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000740 · Cited by 12

Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts

Giavarina, D., Barzon, E., CIGOLINI, M., Mezzena, G., & Soffiati, G. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.12.008 · Cited by 12

Adiponectina, un factor de riesgo cardiovascular emergente. Estudio REFERENCE

Barrios, V., Gómez‐Huelgas, R., Rodríguez, R., & de Pablos-Velasco, P. L. (2008) · Revista Española de Cardiología · doi:10.1157/13127847 · Cited by 12

Global risk assessment for cardiovascular disease and astute clinical judgement

Hennekens, C. H. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.012 · Cited by 12

Statins for Cardiovascular Prevention According to Different Strategies: A Cost Analysis

Ito, M. K., Nanchen, D., Rodondi, N., Paccaud, F., Waeber, G., Vollenweider, P., & Marques-Vidal, P. (2011) · American Journal Cardiovascular Drugs · doi:10.2165/11586760-000000000-00000 · Cited by 11

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration — a Korean translation

Vandenbroucke, J. P., von Elm, E. B., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S., Poole, C., Schlesselman, J. J., & Egger, M. (2024) · Ewha Medical Journal · doi:10.12771/emj.2024.e31 · Cited by 12

Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer–Norfolk Cohort—Invited Commentary

Pencina, M. J. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1216 · Cited by 11

Capacidad predictiva, comparación y consecuencias clínicas de las tablas de Framingham-Wilson y regidor en personas atendidas en un centro de salud de Badajoz

Cañón-Barroso, L., Herrera, N. D., Muro, E. C., Hernández, T. N., Florencio, T. G., & Buitrago, F. (2007) · Revista Española de Salud Pública · doi:10.1590/s1135-57272007000400003 · Cited by 11

MonEco: a Novel Health Monitoring Ecosystem to Predict Respiratory and Cardiovascular Disorders

Lazazzera, R., & Carrault, G. (2022) · IRBM · doi:10.1016/j.irbm.2022.09.003 · Cited by 10

Nuevas herramientas en la estratificación del riesgo cardiovascular

Badimón, J. J., Santos‐Gallego, C. G., Torres, F., Castillo, J., & Kaski, J. C. (2011) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(11)70011-5 · Cited by 10

En la población Canaria, la función de Framingham estima mejor el riesgo de mortalidad cardiovascular que la función SCORE

de León, A. C., Sánchez, J. J. A., Pérez, M. D. C. R., Rodríguez, J. C. D. C., Coello, S. D., Almeida-González, D., Lafuente, B. A., Jaime, A. A., & Díaz, B. B. (2009) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2008.06.003 · Cited by 10

Vergleich internationaler Konsensus-Empfehlungen zur Erkennung des präsymptomatischen Hochrisikopatienten für den Herzinfarkt in Deutschland

von Eckardstein, A., Schulte, H., & Assmann, G. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0150-4 · Cited by 10

Adiponectin: An Emerging Cardiovascular Risk Factor. The REFERENCE Study

Barrios, V., Gómez‐Huelgas, R., Rodríguez, R., & de Pablos-Velasco, P. L. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)60030-x · Cited by 9

Original and REGICOR Framingham Functions in a Nondiabetic Population of a Spanish Health Care Center: A Validation Study

Buitrago, F., Hueros, J. I. C., Cañón-Barroso, L., Pozuelos, G., Molina-Martínez, L. M., Espigares-Arroyo, M., Galán‐González, J., & Lillo-Bravo, F. J. (2011) · The Annals of Family Medicine · doi:10.1370/afm.1287 · Cited by 9

Dyslipidemia: Reduction in Estimated Risk for Coronary Artery Disease After Use of Ezetimibe with a Statin

Sampalis, J. S., Bissonnette, S., Habib, R., & Boukas, S. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k140 · Cited by 9

Tablas para la estimación del riesgo cardiovascular: todavía muchos interrogantes

Mostaza, J. M., & Lahoz, C. (2006) · Medicina Clínica · doi:10.1157/13087151 · Cited by 9

Predictive Accuracy of the European Society of Cardiology SCORE Among French People

Bérard, E., Séguro, F., Bongard, V., Dallongeville, J., Arveiler, D., Amouyel, P., Wagner, A., Ruidavets, J., & Ferrières, J. (2015) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000148 · Cited by 9

Cardiovascular risk assessment methods yield unequal risk predictions: a large cross-sectional study in psychiatric secondary care outpatients

Quadackers, D. M. C., Liemburg, E. J., Bos, F. M., Doornbos, B., Risselada, A., PHAMOUS investigators, Bartels‐Velthuis, A. A., Bruggeman, R., Castelein, S., Jörg, F., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05022-1 · Cited by 8

“First-hit” heart attack risk calculators on the world wide web: Implications for laypersons and healthcare practitioners

Roberts, E., Ramnath, R., Fallows, S. J., & Sykes, K. (2007) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2007.08.001 · Cited by 8

Acute myocardial infarction and anagrelide

Schaaf, M., & Sibellas, F. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.110 · Cited by 7

Assessing fitness, predicting outcome, and the missing axis

Carlisle, J. B. (2012) · British Journal of Anaesthesia · doi:10.1093/bja/aes178 · Cited by 7

State of the art coronary heart disease risk estimations based on the Framingham heart study.

Reissigová, J., & Tomečková, M. (2005) · PubMed · Cited by 7

Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study)

Olkinuora, J., Viikari, J. S. A., Vanhanen, H. T., Makkonen, N., & Kalliomäki, T. (2006) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430600801675 · Cited by 6

Chronic Non-Communicable Disease Risk Calculators – An Overview, Part II

Juchli, F., Zangger, M., Schueck, A., von Wolff, M., & Stute, P. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.10.003 · Cited by 6

Deprivation-based risk scores: the re-emergence of postcode prescribing in the UK?

Payne, R., & Maxwell, S. R. J. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32831fb0c2 · Cited by 6

Coronary Risk Estimation According to the Framingham-Wilson Score: Epidemiologic Behavior of Innovative Cardio Metabolic Risk Factors in the Maracaibo City

Rojas, E. (2013) · International Journal of Cardiovascular Research · doi:10.4172/2324-8602.1000136 · Cited by 5

Cardiovascular Risk Assessment and Effects on Behavior in Switzerland The Swiss Heart Foundation HerzCheck®/Cardio-Test®

Freund, N., Friedli, B., Junker, T., Zimmermann, M., & Zellweger, M. J. (2015) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401509010035 · Cited by 5

Kidney Function and Estimated Vascular Risk in Patients with Primary Dyslipidemia

Τζιόμαλος, Κ., Ganotakis, E. S., Gazi, I. F., Nair, D. R., & Mikhailidis, D. P. (2009) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192400903010057 · Cited by 5

Cardiovascular risk assessment--time to look beyond cohort studies

Brindle, P. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh188 · Cited by 5

Eventos cardiovasculares en una población cerrada. Seguimiento a 10 años

Tartaglione, J. E., Grazioli, G., Sarmiento, M., & Goldstraj, L. M. (2026) · Revista Argentina de Cardiología · doi:10.7775/wef00j91 · Cited by 4

COMPARATIVE ANALYSIS OF THE CALCULATION MODELS FOR ISCHEMIC HEART DISEASE OVERALL RISK IN RAILROAD WORKERS

Gorokhova, S. G., Muraseeva, E. V., Пфаф, В. Ф., Sboev, A. G., Александрович, М. И., & Atkov, O. Y. (2016) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2016-6-27-33 · Cited by 4

Chronic non-communicable disease risk calculators – An overview, part I

Juchli, F., Zangger, M., Schueck, A., von Wolff, M., & Stute, P. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.07.009 · Cited by 4

Cardiovascular Risk Calculators and their Applicability to South Asians

Bansal, M., Ranjan, S., & Kasliwal, R. R. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816999201001204020 · Cited by 5

Stellenwert von Kardio-CT und Kardio-MR zur Bestimmung des koronaren Risikos

Silber, S., & Richartz, B. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-1416-6 · Cited by 4

Could clinical decision rules relying on cardiovascular risk models increase psychosocial inequalities in health? Results from the PRIME cohort study

Lepage, B., Amouyel, P., Arveiler, D., Ferrières, J., Ducimetière, P., & Lang, T. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.04.006 · Cited by 4

Évaluation du risque cardiovasculaire

Ferrières, J. (2012) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(12)70840-6 · Cited by 4

COSEHC global vascular risk management quality improvement program: rationale and design

Ferrario, C. M. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s13746 · Cited by 4

Risk assessment of myocardial infarction and stroke

Assmann, G., Cullen, P., & Schulte, H. (2004) · International Congress Series · doi:10.1016/j.ics.2004.01.100 · Cited by 4

Prolonged-Release Nicotinic Acid in Patients with Atherosclerotic Disease in The Netherlands

Poldermans, D., Dunkelgrun, M., Schouten, O., & Hostalek, U. (2008) · European Surgical Research · doi:10.1159/000155896 · Cited by 5

Framingham-Grundy, REGICOR y SCORE en la estimación del riesgo cardiovascular del paciente hipertenso. Concordancias y discrepancias (CICLO-RISK)

García‐Ortiz, L., Gómez-Marcos, M. Á., González-Elena, L. J., Rodríguez‐Sánchez, E., Garcı́a, A. G., Parra-Sánchez, J., García, A. M. G., Rodríguez, C. H., & Barrientos, L. M. (2006) · Hipertensión · doi:10.1016/s0212-8241(06)71734-0 · Cited by 4

Intima-Media Thickness and Carotid Plaques in Cardiovascular Risk Assessment

To, T.-D., & Naqvi, T. Z. (2011) · Springer eBooks · doi:10.1007/978-1-84882-688-5_23 · Cited by 3

Carotid intima-media thickness and carotid plaques in cardiovascular risk assessment

Daneshvar, S. A., & Naqvi, T. Z. (2009) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0020-0 · Cited by 3

Psychosoziale Belastungsfaktoren als Risiko für das Auftreten einer koronaren Herzerkrankung - Eine Bestandsaufnahme unter besonderer Berücksichtigung der KORA-Forschungsplattform

Ladwig, K., Marten‐Mittag, B., & Baumert, J. J. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858249 · Cited by 3

Randomization and Rules for Causal Inferences in Biology: When the Biological Emperor (Significance Testing) Has No Clothes

Shrader-Frechette, K. (2011) · Biological Theory · doi:10.1007/s13752-012-0021-y · Cited by 3

Hypercholesterolemia, eligibility for lipid-lowering therapy and therapeutic success: population-based study in a Portuguese urban population

Alves, L., & Azevedo, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0487 · Cited by 3

General practitioners’ coronary risk assessments and lipid-lowering treatment decisions in primary prevention: comparison between two European areas with different cardiovascular risk levels

Vancheri, F., Strender, L., Bring, J., Montgomery, H., Skånér, Y., & Backlund, L. G. (2008) · Primary Health Care Research & Development · doi:10.1017/s146342360800090x · Cited by 3

Physicians' estimates of the 10 year cardiovascular risk in hypertensive patients: An evaluation in primary care physicians in training

Senn, M. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11330 · Cited by 3

Evaluation of Coronary Risk Score Applications in 10-Year Coronary Heart Risk Estimation

Eremić, N., & Đerić, M. (2009) · Journal of Medical Biochemistry · doi:10.2478/v10011-009-0008-9 · Cited by 3

Research inefficiencies in external validation studies of the Framingham Wilson coronary heart disease risk rule: A systematic review

Ban, J.-W., Abel, L., Stevens, R., & Perera, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310321 · Cited by 2

Amlodipine Reduces Predicted Risk of Coronary Heart Disease in High-Risk Patients with Hypertension in Spain (The CORONARIA Study)

Zamorano, J. L., Padial, L. R., Cosín, J., Martínez, A. H., Gutiérrez‐Chico, J. L., de Isla, L. P., Arístegui, R., & Masramon, X. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600630 · Cited by 2

Lipoproteins and diabetes

Lüscher, T. F. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv003 · Cited by 2

Editorial Global risk assessment for cardiovascular disease and astute clinical judgement

Hennekensa, C. H., & D'agostinob, R. B. (2003)

Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men

Haq, I. U., Ramsay, L. E., Yeo, W. W., Jackson, P., & Wallis, E. J. (1999) · Heart · doi:10.1136/hrt.81.1.40 · Cited by 214

P1621 Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME study

Empana, J. P. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)94759-2

External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study

Majed, B., Tafflet, M., Kee, F., Haas, B., Ferrières, J., Montaye, M., Ruidavets, J., Arveiler, D., Yarnell, J., Amouyel, P., et al. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.04.003 · Cited by 25

Global risk assessment for cardiovascular disease and astute clinical judgement

Hennekens, C. H. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.012 · Cited by 12